Matthew Porteus

Matthew Porteus

Corporate Officer/Principal chez
Stanford School of Medicine
61 ans
Consumer Services
Health Technology

Profil

Matthew Porteus is the founder of CRISPR Therapeutics AG, founded in 2013.
Dr. Porteus was the founder of Graphite Bio, Inc., founded in 2017, and served as Director.
Dr. Porteus is also the founder of Kamau Therapeutics, Inc...
Dr. Porteus is a Professor at Stanford University.
Dr. Porteus is an Associate Professor at Stanford School of Medicine since 2010.
Dr. Porteus was an Assistant Professor at The University of Texas Southwestern Medical Center from 2003 to 2010.
Dr. Porteus completed undergraduate studies at Harvard University.
Dr. Porteus earned a doctorate from Stanford University.

Postes actifs de Matthew Porteus

SociétésPosteDébut
Corporate Officer/Principal 01/10/2010
Corporate Officer/Principal -

Anciens postes connus de Matthew Porteus

SociétésPosteFin
Corporate Officer/Principal 01/08/2010
LENZ THERAPEUTICS, INC. Fondateur -
CRISPR THERAPEUTICS AG Fondateur -
Voir l'expérience en détail de Matthew Porteus

Formation de Matthew Porteus

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

94

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Consumer Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Matthew Porteus